{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:51:56Z","timestamp":1793641916465,"version":"4.5.1"},"reference-count":100,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Management of infections in heart transplant recipients is complex and crucial. In this\npopulation, there is a need for a better understanding of immunosuppressive trough levels (C0), infectious\ncomplications, and urinary tract infections (UTIs). The purpose of this review was to understand\nthe association between immunosuppressive trough levels and UTIs after heart transplantation.\nA review of scientific literature (n= 100) was conducted based on the topic of interest by\nsearching PUBMED.Gov (https:\/\/pubmed.ncbi.nlm.nih.gov\/), Web of Science, and Scopus. The\nanalysis of bacterial pulmonary infection required the occurrence of new or deteriorating pulmonary\ninfiltrates and the development of organisms in cultures of sputum specimens. The diagnosis\nof UTIs was based on the result of related signs, pyuria, and a positive urine culture. The incidence\nof UTIs was reported as 0.07 episodes\/1000 regarding heart transplantation days. An eightfold\nincrease in the rate of rejection was noted in heart transplant recipients with higher variability\nin tacrolimus C0. There are associations between C0 of immunosuppressive drugs and clinical presentation\nof infection complications. Recipients with a low metabolism of immunosuppressive\ndrugs are more susceptible to infectious complications. Attention to the biology of herpes viruses,\n&lt;i&gt;Escherichia coli, Enterococcus spp., Pseudomonas aeruginosa&lt;\/i&gt;, and &lt;i&gt;Staphylococcus saprophyticus&lt;\/i&gt;\nafter heart transplantation are important, in which some of them are the most common pathogens\nresponsible for UTIs. Pneumocystis and cytomegalovirus affect all transplant recipients. Pneumonia\ndue to bacterial, viral, protozoa, and fungal infections, in addition to UTIs, are more specific reported\ntypes of infections in heart transplant recipients. Bacterial infections produced by extensively\ndrug-resistant Enterobacteriaceae, vancomycin-resistant enterococci, and non-fermenting gramnegative\nbacteria were reported to increase after transplantation.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115748871315445240916091528","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T07:11:03Z","timestamp":1727334663000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Review of Association between Urinary Tract Infections and Immunosuppressive Drugs after Heart Transplantation"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-0211","authenticated-orcid":true,"given":"Zahra","family":"Tolou-Ghamari","sequence":"first","affiliation":[{"name":"Nutrition and Food Security Research Center, Deputy of Research and Technology, Isfahan University of Medical Sciences,\nIsfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S305","DOI":"10.1016\/j.ajt.2024.01.016","volume":"24","author":"Colvin MM","year":"2024","unstructured":"Colvin MM; Smith JM; Ahn YS; Handarova DK; Martinez AC; Lindblad KA; Israni AK; Snyder JJ; OPTN\/SRTR 2022 annual data report: Heart. Am J Transplant  2024,24(2S1),S305-S393","journal-title":"Am J Transplant"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3978\/j.issn.2072-1439.2014.06.44","volume":"6","author":"Alraies M.C.","year":"2014","unstructured":"Alraies M.C.; Eckman P.; Adult heart transplant: Indications and outcomes. J Thorac Dis  2014,6(8),1120-1128","journal-title":"J Thorac Dis"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9034-4_2","author":"Henao-Mart\u00ednez AF","year":"2018","unstructured":"Henao-Mart\u00ednez AF; Montoya JG;  Principles and practice of transplant infectious diseases  2018","journal-title":"Principles and practice of transplant infectious diseases"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7326\/0003-4819-74-1-22","volume":"74","author":"Stinson E.B.","year":"1971","unstructured":"Stinson E.B.; Bieber C.P.; Griepp R.B.; Clark D.A.; Shumway N.E.; Remington J.S.; Infectious complications after cardiac transplantation in man. Ann Intern Med  1971,74(1),22-36","journal-title":"Ann Intern Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.healun.2009.08.018","volume":"29","author":"Haddad F.","year":"2010","unstructured":"Haddad F.; Deuse T.; Pham M.; Khazanie P.; Rosso F.; Luikart H.; Valantine H.; Leon S.; Vu T.A.; Hunt S.A.; Oyer P.; Montoya J.G.; Changing trends in infectious disease in heart transplantation. J Heart Lung Transplant  2010,29(3),306-315","journal-title":"J Heart Lung Transplant"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13613-019-0490-2","volume":"9","author":"Pons S.","year":"2019","unstructured":"Pons S.; Sonneville R.; Bouadma L.; Styfalova L.; Ruckly S.; Neuville M.; Radjou A.; Lebut J.; Dilly M.P.; Mourvillier B.; Dorent R.; Nataf P.; Wolff M.; Timsit J.F.; Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation. Ann Intensive Care  2019,9(1),17","journal-title":"Ann Intensive Care"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12879-023-08641-x","volume":"23","author":"Mlugu E.M.","year":"2023","unstructured":"Mlugu E.M.; Mohamedi J.A.; Sangeda R.Z.; Mwambete K.D.; Prevalence of urinary tract infection and antimicrobial resistance patterns of uropathogens with biofilm forming capacity among outpatients in morogoro, Tanzania: A cross-sectional study. BMC Infect Dis  2023,23(1),660","journal-title":"BMC Infect Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1089\/sur.2013.115","volume":"16","author":"Gillen J.R.","year":"2015","unstructured":"Gillen J.R.; Isbell J.M.; Michaels A.D.; Lau C.L.; Sawyer R.G.; Risk factors for urinary tract infections in cardiac surgical patients. Surg Infect (Larchmt)  2015,16(5),504-508","journal-title":"Surg Infect (Larchmt)"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1177\/1756287219832172","volume":"11","author":"Medina M.","year":"2019","unstructured":"Medina M.; Castillo-Pino E.; An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol  2019,11","journal-title":"Ther Adv Urol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/jcm11010226","volume":"11","author":"Strohaeker J.","year":"2021","unstructured":"Strohaeker J.; Aschke V.; Koenigsrainer A.; Nadalin S.; Bachmann R.; Urinary tract infections in kidney transplant recipients\u2014is there a need for antibiotic stewardship? J Clin Med  2021,11(1),226","journal-title":"J Clin Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/3033276","volume":"2021","author":"Arabi Z.","year":"2021","unstructured":"Arabi Z.; Al Thiab K.; Altheaby A.; Aboalsamh G.; Kashkoush S.; Almarastani M.; Shaheen M.F.; Altamimi A.; O\u2019hali W.; Bin Saad K.; Alnajjar L.; Alhussein R.; Almuhiteb R.; Alqahtani B.; Alotaibi R.; Alqahtani M.; Tawhari M.; Urinary tract infections in the first 6 months after renal transplantation. Int J Nephrol  2021,2021,1-8","journal-title":"Int J Nephrol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"679.e1","DOI":"10.1016\/j.eimc.2015.03.024","volume":"33","author":"Vidal E.","year":"2015","unstructured":"Vidal E.; Cervera C.; Cordero E.; Armi\u00f1anzas C.; Carratal\u00e1 J.; Cisneros J.M.; Fari\u00f1as M.C.; L\u00f3pez-Medrano F.; Moreno A.; Mu\u00f1oz P.; Orig\u00fcen J.; Sab\u00e9 N.; Valerio M.; Torre-Cisneros J.; Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). Enferm Infecc Microbiol Clin  2015,33(10),679.e1-679.e21","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jceh.2023.01.003","volume":"13","author":"Wadhawan M.","year":"2023","unstructured":"Wadhawan M.; Gupta C.; Immunosuppression Monitoring\u2014What Clinician Needs to Know? J Clin Exp Hepatol  2023,13(4),691-697","journal-title":"J Clin Exp Hepatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12882-019-1666-6","volume":"20","author":"Olenski S.","year":"2019","unstructured":"Olenski S.; Scuderi C.; Choo A.; Bhagat Singh A.K.; Way M.; Jeyaseelan L.; John G.; Urinary tract infections in renal transplant recipients at a quaternary care centre in Australia. BMC Nephrol  2019,20(1),479","journal-title":"BMC Nephrol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/00007890-201211271-01669","volume":"94","author":"Giordano L.F.C.","year":"2012","unstructured":"Giordano L.F.C.; Lasmar M.F.; Vianna H.R.; Lasmar L.F.; Palma R.V.S.; Domiciano J.; Lasmar E.P.; Risk factors related to urinary tract infection in renal transplant recipients: 539. Transplantation  2012,94(10S),849","journal-title":"Transplantation"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4103\/ijn.IJN_331_16","volume":"27","author":"Lakshmi V.","year":"2017","unstructured":"Lakshmi V.; Mohan M.V.N.L.R.; Neeraja M.; Sudhaharan S.; Raju S.B.; Gangadhar T.; Risk factors for urinary tract infections in renal allograft recipients: Experience of a tertiary care center in Hyderabad, South India. Indian J Nephrol  2017,27(5),372-376","journal-title":"Indian J Nephrol"},{"key":"ref=17","volume":"17","author":"Hooker D.G.K.","year":"2017","unstructured":"Hooker D.G.K.; Foster K.; Dodson A.; Multi-drug resistant urinary tract infections following renal transplant: Risk factors and patient outcomes. Am J Transplant  2017,17(3)","journal-title":"Am J Transplant"},{"key":"ref=18","first-page":"562","volume":"16","author":"Shaheen F.A.","year":"2005","unstructured":"Shaheen F.A.; Basri N.; Mohammed Z.; Abdullah K.; Haider R.; Awad A.; Nasser A.; El Gabarty A.; Experience of renal transplantation at the king fahd hospital, Jeddah, Saudi Arabia. Saudi J Kidney Dis Transpl  2005,16(4),562-572","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5897\/JIDI12.026","volume":"5","author":"Alkatheri M.","year":"2013","unstructured":"Alkatheri M.; Urinary tract infections in Saudi renal transplant recipients. J Infect Dis Immun  2013,5(2),18-23","journal-title":"J Infect Dis Immun"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3855\/jidc.5202","volume":"8","author":"Alkatheri A.M.","year":"2014","unstructured":"Alkatheri A.M.; Albekairy A.M.; Alharbi S.; Aldekhael S.N.; Khalidi N.; Alsayyari A.A.; Abdel-Razaq W.S.; Qandil A.M.; Investigation of the effectiveness of antibacterial prophylaxis in renal transplant recipients. J Infect Dev Ctries  2014,8(10),1244-1251","journal-title":"J Infect Dev Ctries"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/lt.22291","volume":"17","author":"Razonable R.R.","year":"2011","unstructured":"Razonable R.R.; Findlay J.Y.; O\u2019Riordan A.; Burroughs S.G.; Ghobrial R.M.; Agarwal B.; Davenport A.; Gropper M.; Critical care issues in patients after liver transplantation. Liver Transpl  2011,17(5),511-527","journal-title":"Liver Transpl"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/lt.22284","volume":"17","author":"San-Juan R.","year":"2011","unstructured":"San-Juan R.; Aguado J.M.; Lumbreras C.; Fortun J.; Len O.; Munoz P.; Montejo M.; Moreno A.; Cordero E.; Blanes M.; Ramos A.; Torre-Cisneros J.; L\u00f3pez-Medrano F.; Carratala J.; Moreno E.; Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation. Liver Transpl  2011,17(8),896-904","journal-title":"Liver Transpl"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.3390\/biomedicines10112984","volume":"10","author":"Santithanmakorn C.","year":"2022","unstructured":"Santithanmakorn C.; Vanichanan J.; Townamchai N.; Jutivorakool K.; Wattanatorn S.; Sutherasan M.; Opanuruk J.; Kerr S.J.; Praditpornsilpa K.; Avihingsanon Y.; Udomkarnjananun S.; Bacterial urinary tract infection and early asymptomatic bacteriuria in kidney transplantation still negatively affect kidney transplant outcomes in the era of modern immunosuppression and cotrimoxazole prophylaxis. Biomedicines  2022,10(11),2984","journal-title":"Biomedicines"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.4103\/ijot.ijot_85_21","volume":"16","author":"Prasannakumar P","year":"2022","unstructured":"Prasannakumar P; Gadde AB; Bansal SB; Rupali P; Expert group opinion for respiratory infections in solid organ transplant recipients in South Asia. Indian J Transplant  2022,16(Suppl 1),S98-S105","journal-title":"Indian J Transplant"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e13896","DOI":"10.1111\/tid.13896","volume":"24","author":"Imlay H.","year":"2022","unstructured":"Imlay H.; Spellberg B.; Shorter is better: The case for short antibiotic courses for common infections in solid organ transplant recipients. Transpl Infect Dis  2022,24(5),e13896","journal-title":"Transpl Infect Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/1871525721666230726150021","volume":"22","author":"Tolou-Ghamari Z.","year":"2023","unstructured":"Tolou-Ghamari Z.; Tacrolimus and cyclosporin pharmacotherapy, detection methods, cytochrome p450 enzymes after heart transplantation. Cardiovasc Hematol Agents Med Chem  2023,22(2),106-113","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2174\/0115748855271275231115064229","volume":"19","author":"Tolou-Ghamari Z.","year":"2024","unstructured":"Tolou-Ghamari Z.; Investigation of nosocomial urinary tract infections post transplantation, main pathogens, and sensitivity tests. Curr Drug Ther  2024,19(7),846-850","journal-title":"Curr Drug Ther"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"73240","DOI":"10.2174\/0125899775259326231212073240","volume":"2023","author":"Tolou Ghamari Z.","year":"2023","unstructured":"Tolou Ghamari Z.; Palizban A.A.; Tacrolimus pharmacotherapy: Infectious complications and toxicity in organ transplant recipients; an updated review. Curr Drug Res Rev  2023,2023,73240","journal-title":"Curr Drug Res Rev"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/2277-9175.151876","volume":"4","author":"Tolou-Ghamari Z","year":"2015","unstructured":"Tolou-Ghamari Z; Mortazavi M; Palizban AA; Najafi MR; The investigation of the correlation between iminoral concentration and neurotoxic levels after kidney transplantation. Adv Biomed Res  2015,4,59","journal-title":"Adv Biomed Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2165\/00126839-200405010-00003","volume":"5","author":"Tolou-Ghamari Z.","year":"2004","unstructured":"Tolou-Ghamari Z.; Palizban A.A.; Michael Tredger J.; Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay. Drugs R D  2004,5(1),17-22","journal-title":"Drugs R D"},{"key":"ref=31","first-page":"e32670","volume":"5","author":"Tolou-Ghamari Z","year":"2016","unstructured":"Tolou-Ghamari Z; Sanei B.; Prograf concentrations in liver transplantation: Correlation with headache and other neurotoxic complications? Thrita J Neuron  2016,5(1),e32670","journal-title":"Thrita J Neuron"},{"key":"ref=32","first-page":"34","volume":"6","author":"Tolou-Ghamari Z","year":"2019","unstructured":"Tolou-Ghamari Z; Monitoring heart transplant recipients in order to investigate immunosuppressive drug absorption using pharmacokinetics parameters and its\u2019 correlation with nephrotoxicity. AJECR  2019,6(4),34","journal-title":"AJECR"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"101316","DOI":"10.1016\/j.cpcardiol.2022.101316","volume":"47","author":"Rangel-Ugarte P.M.","year":"2022","unstructured":"Rangel-Ugarte P.M.; Ramirez-Casta\u00f1eda S.; Mendoza-Lopez A.C.; Gonzalez-Hermosillo L.M.; Flores-Calderon O.; Salazar-Hernandez I.; Ramirez-Casta\u00f1eda A.; Roldan-Valadez E.; Evolution and current circumstances of heart transplants: Global and mexican perspective. Curr Probl Cardiol  2022,47(10),101316","journal-title":"Curr Probl Cardiol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.21470\/1678-9741-2017-0508","volume":"32","author":"Stolf N.A.G.","year":"2017","unstructured":"Stolf N.A.G.; History of heart transplantation: A hard and glorious journey. Rev Bras Cir Cardiovasc  2017,32(5),423-427","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"ref=35","first-page":"1271","volume":"41","author":"Barnard C.N.","year":"1967","unstructured":"Barnard C.N.; The operation. A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J  1967,41(48),1271-1274","journal-title":"S Afr Med J"},{"key":"ref=36","first-page":"35","volume":"2008","author":"Everly M.J.","year":"2008","unstructured":"Everly M.J.; Cardiac transplantation in the United States: An analysis of the UNOS registry. Clin Transpl  2008,2008,35-43","journal-title":"Clin Transpl"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.athoracsur.2024.05.013","volume":"118","author":"Bakhtiyar S.S.","year":"2024","unstructured":"Bakhtiyar S.S.; Sakowitz S.; Mallick S.; Curry J.; Benharash P.; Heart transplantation after donation after circulatory death: Early United States experience. Ann Thorac Surg  2024,118(2),484-493","journal-title":"Ann Thorac Surg"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/phar.2481","volume":"41","author":"Pilch N.A.","year":"2021","unstructured":"Pilch N.A.; Bowman L.J.; Taber D.J.; Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management. Pharmacotherapy  2021,41(1),119-131","journal-title":"Pharmacotherapy"},{"key":"ref=39","author":"Tolou_Ghamari Z.","year":"1999","unstructured":"Tolou_Ghamari Z.;  Monitoring tacrolimus after liver transplantation; consideration of alternative techniques and the influence of clinical status  1999","journal-title":"Monitoring tacrolimus after liver transplantation; consideration of alternative techniques and the influence of clinical status"},{"key":"ref=40","first-page":"109","volume":"16","author":"Tolou-Ghamari Z.","year":"2004","unstructured":"Tolou-Ghamari Z.; Palizban A.A.; Tredger J.M.; Modelling tacrolimus AUC in acute and chronic liver disease immediately after transplant. Transplantationsmedizin. Organ der Deutschen Transplantationsgesellschaft  2004,16(2),109-111","journal-title":"Organ der Deutschen Transplantationsgesellschaft"},{"key":"ref=41","first-page":"112","volume":"16","author":"Tolou-Ghamari Z.","year":"2004","unstructured":"Tolou-Ghamari Z.; Palizban A.A.; Wendon J.; Tredger J.M.; Pharmacokinetics of tacrolimus immediately after liver transplantation. Transplantationsmedizin. Organ der Deutschen Transplantationsgesellschaft  2004,16(2),112-116","journal-title":"Organ der Deutschen Transplantationsgesellschaft"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.2215\/CJN.03510807","volume":"3 Suppl 2","author":"Srinivas TR","year":"2008","unstructured":"Srinivas TR; Meier-Kriesche HU; Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result. Clin J Am Soc Nephrol  2008,3 Suppl 2(Suppl 2),S101-16","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5812\/jnp.6","volume":"1","author":"Tolou-Ghamari Z.","year":"2012","unstructured":"Tolou-Ghamari Z.; Nephro and neurotoxicity of calcineurin inhibitors and mechanisms of rejections: A review on tacrolimus and cyclosporin in organ transplantation. J Nephropathol  2012,1(1),23-30","journal-title":"J Nephropathol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.36628\/ijhf.2020.0034","volume":"3","author":"Chang D.H.","year":"2021","unstructured":"Chang D.H.; Youn J.C.; Dilibero D.; Patel J.K.; Kobashigawa J.A.; Heart transplant immunosuppression strategies at cedars-sinai medical center. Int J Heart Fail  2021,3(1),15-30","journal-title":"Int J Heart Fail"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1111\/ajt.15016","volume":"18","author":"Gueta I.","year":"2018","unstructured":"Gueta I.; Markovits N.; Yarden-Bilavsky H.; Raichlin E.; Freimark D.; Lavee J.; Loebstein R.; Peled Y.; High tacrolimus trough level variability is associated with rejections after heart transplant. Am J Transplant  2018,18(10),2571-2578","journal-title":"Am J Transplant"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4103\/ijp.ijp_950_20","volume":"54","author":"Abhisek P.A.","year":"2022","unstructured":"Abhisek P.A.; Srivastava A.; Pradhan S.; An idiosyncratic reaction of unilateral common peroneal nerve palsy associated with below desired therapeutic range of tacrolimus level in a patient postheart transplantation. Indian J Pharmacol  2022,54(6),459-461","journal-title":"Indian J Pharmacol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3390\/pharmaceutics14061247","volume":"14","author":"De Gregori S.","year":"2022","unstructured":"De Gregori S.; De Silvestri A.; Cattadori B.; Rapagnani A.; Albertini R.; Novello E.; Concardi M.; Arbustini E.; Pellegrini C.; Therapeutic drug monitoring of tacrolimus-personalized therapy in heart transplantation: New strategies and preliminary results in endomyocardial biopsies. Pharmaceutics  2022,14(6),1247","journal-title":"Pharmaceutics"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.healun.2021.02.017","volume":"40","author":"Godinas L.","year":"2021","unstructured":"Godinas L.; Dobbels F.; Hulst L.; Verbeeck I.; De Coninck I.; Berrevoets P.; Schaevers V.; Yserbyt J.; Dupont L.J.; Verleden S.E.; Vanaudenaerde B.M.; Ceulemans L.J.; Van Raemdonck D.E.; Neyrinck A.; Verleden G.M.; Vos R.; Once daily tacrolimus conversion in lung transplantation: A prospective study on safety and medication adherence. J Heart Lung Transplant  2021,40(6),467-477","journal-title":"J Heart Lung Transplant"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e13716","DOI":"10.1111\/tid.13716","volume":"23","author":"Nnani D.U.","year":"2021","unstructured":"Nnani D.U.; Campbell A.; Ajaimy M.; Saeed O.; Patel S.R.; Ahmed S.; Graham J.A.; Jorde U.P.; Effect of glecaprevir\/pibrentasvir on weight-adjusted tacrolimus trough\/dose ratios in heart and kidney transplant recipients. Transpl Infect Dis  2021,23(5),e13716","journal-title":"Transpl Infect Dis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e13851","DOI":"10.1111\/tid.13851","volume":"24","author":"Silva J.T.","year":"2022","unstructured":"Silva J.T.; Aguado J.M.; Current state of antimicrobial stewardship and organ transplantation in Spain. Transpl Infect Dis  2022,24(5),e13851","journal-title":"Transpl Infect Dis"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e2141089","DOI":"10.1001\/jamanetworkopen.2021.41089","volume":"4","author":"Hosseini-Moghaddam S.M.","year":"2021","unstructured":"Hosseini-Moghaddam S.M.; Luo B.; Bota S.E.; Husain S.; Silverman M.S.; Daneman N.; Brown K.A.; Paterson J.M.; Incidence and outcomes associated with clostridioides difficile infection in solid organ transplant recipients. JAMA Netw Open  2021,4(12),e2141089","journal-title":"JAMA Netw Open"},{"key":"ref=52","first-page":"166","volume":"64","author":"Fakhredine S","year":"2022","unstructured":"Fakhredine S; Oravec T; Belga S; Wright A; Mah A, MD; Management of common infections in solid organ transplant recipients in British Columbia. BCMJ  2022,64(4),166-173","journal-title":"BCMJ"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1170.e1","DOI":"10.1016\/j.cmi.2020.09.042","volume":"27","author":"Escribano P.","year":"2021","unstructured":"Escribano P.; Rodr\u00edguez-S\u00e1nchez B.; D\u00edaz-Garc\u00eda J.; Mart\u00edn-G\u00f3mez M.T.; Ib\u00e1\u00f1ez-Mart\u00ednez E.; Rodr\u00edguez-Mayo M.; Pel\u00e1ez T.; Garc\u00eda-G\u00f3mez de la Pedrosa E.; Tejero-Garc\u00eda R.; Marim\u00f3n J.M.; Reigadas E.; Rezusta A.; Labayru-Echeverr\u00eda C.; P\u00e9rez-Ayala A.; Ayats J.; Cobo F.; Pazos C.; L\u00f3pez-Soria L.; Alastruey-Izquierdo A.; Mu\u00f1oz P.; Guinea J.; S\u00e1nchez-Yebra W.; S\u00e1nchez-G\u00f3mez J.; Lozano I.; Marfil E.; Mu\u00f1oz de la Rosa M.; Garc\u00eda R.T.; Cobo F.; Castro C.; L\u00f3pez C.; Rezusta A.; Pel\u00e1ez T.; Castell\u00f3-Abietar C.; Costales I.; Serra J.L.; Jim\u00e9nez R.; Echeverr\u00eda C.L.; P\u00e9rez C.L.; Meg\u00edas-Lob\u00f3n G.; Lorenzo B.; S\u00e1nchez-Reus F.; Ayats J.; Mart\u00edn M.T.; Vidal I.; S\u00e1nchez-Hell\u00edn V.; Ib\u00e1\u00f1ez E.; Pem\u00e1n J.; Fajardo M.; Pazos C.; Rodr\u00edguez-Mayo M.; P\u00e9rez-Ayala A.; G\u00f3mez E.; Guinea J.; Escribano P.; Serrano J.; Reigadas E.; Rodr\u00edguez B.; Zvezdanova E.; D\u00edaz-Garc\u00eda J.; G\u00f3mez-N\u00fa\u00f1ez A.; Leiva J.G.; Machado M.; Mu\u00f1oz P.; S\u00e1nchez-Romero I.; Garc\u00eda-Rodr\u00edguez J.; Luis del Pozo J.; Vallejo M.R.; Ruiz de Alegr\u00eda-Puig C.; L\u00f3pez-Soria L.; Marim\u00f3n J.M.; Vicente D.; Fern\u00e1ndez-Torres M.; Hern\u00e1ez-Crespo S.; Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain. Clin Microbiol Infect  2021,27(8),1170.e1-1170.e7","journal-title":"Clin Microbiol Infect"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.transproceed.2017.09.058","volume":"50","author":"Cintra-Cabrera M.","year":"2018","unstructured":"Cintra-Cabrera M.; Su\u00e1rez-Benjumea A.; Bernal-Blanco G.; Gonz\u00e1lez-Roncero F.M.; Toapanta-Gaibor N.G.; S\u00fa\u00f1er-Poblet M.; P\u00e9rez-Valdivia M.\u00c1.; Fern\u00e1ndez-Cuenca F.; Gentil-Govantes M.\u00c1.; Rocha-Castilla J.L.; Resistant cytomegalovirus infection after renal transplantation: Literature review. Transplant Proc  2018,50(2),575-577","journal-title":"Transplant Proc"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e13507","DOI":"10.1111\/ctr.13507","volume":"33","author":"Goldman J.D.","year":"2019","unstructured":"Goldman J.D.; Julian K.; Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant  2019,33(9),e13507","journal-title":"Clin Transplant"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"861374","DOI":"10.3389\/fcimb.2022.861374","volume":"12","author":"Krawczyk B.","year":"2022","unstructured":"Krawczyk B.; Wysocka M.; Michalik M.; Go\u0142\u0119biewska J.; Urinary tract infections Caused by K. pneumoniae in kidney transplant recipients \u2013 epidemiology, virulence and antibiotic resistance. Front Cell Infect Microbiol  2022,12,861374","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0025-7125(16)30461-8","volume":"75","author":"Korzeniowski O.M.","year":"1991","unstructured":"Korzeniowski O.M.; Urinary tract infection in the impaired host. Med Clin North Am  1991,75(2),391-404","journal-title":"Med Clin North Am"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0009-8981(01)00525-3","volume":"310","author":"Fischer K.","year":"2001","unstructured":"Fischer K.; Hamza A.; Eismann R.; Amoury M.; Heynemann H.; Fornara P.; Differential diagnostic use of interleukin patterns in patients being monitored after transplantation. Clin Chim Acta  2001,310(1),71-80","journal-title":"Clin Chim Acta"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1104.e1","DOI":"10.1016\/j.cmi.2015.07.019","volume":"21","author":"Bodro M.","year":"2015","unstructured":"Bodro M.; Sanclemente G.; Lipperheide I.; Allali M.; Marco F.; Bosch J.; Cofan F.; Ricart M.J.; Esforzado N.; Oppenheimer F.; Moreno A.; Cervera C.; Impact of urinary tract infections on short-term kidney graft outcome. Clin Microbiol Infect  2015,21(12),1104.e1-1104.e8","journal-title":"Clin Microbiol Infect"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/j.ackd.2019.08.001","volume":"27","author":"Morales-Alvarez M.C.","year":"2020","unstructured":"Morales-Alvarez M.C.; Nephrotoxicity of antimicrobials and antibiotics. Adv Chronic Kidney Dis  2020,27(1),31-37","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40620-019-00591-5","volume":"32","author":"Pesce F.","year":"2019","unstructured":"Pesce F.; Martino M.; Fiorentino M.; Rollo T.; Simone S.; Gallo P.; Stallone G.; Grandaliano G.; Schena A.; Margiotta M.; Mininni D.; Palieri R.; Lucarelli G.; Battaglia M.; Gesualdo L.; Castellano G.; Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: A single-center retrospective cohort study. J Nephrol  2019,32(4),661-668","journal-title":"J Nephrol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"E350","DOI":"10.5489\/cuaj.4434","volume":"11","author":"Cox L.","year":"2017","unstructured":"Cox L.; He C.; Bevins J.; Clemens J.Q.; Stoffel J.T.; Cameron A.P.; Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization. Can Urol Assoc J  2017,11(9),E350-E354","journal-title":"Can Urol Assoc J"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1097\/TP.0000000000004607","volume":"107","author":"Kim J.Y.V.","year":"2023","unstructured":"Kim J.Y.V.; Assadian S.; Hollander Z.; Burns P.; Shannon C.P.; Lam K.; Toma M.; Ignaszewski A.; Davies R.A.; Delgado D.; Haddad H.; Isaac D.; Kim D.; Mui A.; Rajda M.; West L.; White M.; Zieroth S.; Keown P.A.; McMaster W.R.; Ng R.T.; McManus B.M.; Levings M.K.; Tebbutt S.J.; Regulatory T.; Regulatory T Cell Biomarkers identify patients at risk of developing acute cellular rejection in the first year following heart transplantation. Transplantation  2023,107(8),1810-1819","journal-title":"Transplantation"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13318-022-00807-3","volume":"48","author":"Cheng Y.","year":"2023","unstructured":"Cheng Y.; Chen J.; Lin X.; Qiu H.; Zhang J.; Population pharmacokinetic analysis for model-based therapeutic drug monitoring of tacrolimus in chinese han heart transplant patients. Eur J Drug Metab Pharmacokinet  2023,48(1),89-100","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"507","DOI":"10.31729\/jnma.7496","volume":"60","author":"Khatri B.","year":"2022","unstructured":"Khatri B.; Maharjan S.; Lamsal J.; Khatri B.; Singh Shah D.; Urinary tract infection among post-renal transplant patients in the department of nephrology of a tertiary care centre: A descriptive cross-sectional study. JNMA J Nepal Med Assoc  2022,60(250),507-510","journal-title":"JNMA J Nepal Med Assoc"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1399-0012.2006.00519.x","volume":"20","author":"Alangaden G.J.","year":"2006","unstructured":"Alangaden G.J.; Thyagarajan R.; Gruber S.A.; Morawski K.; Garnick J.; El-Amm J.M.; West M.S.; Sillix D.H.; Chandrasekar P.H.; Haririan A.; Infectious complications after kidney transplantation: Current epidemiology and associated risk factors. Clin Transplant  2006,20(4),401-409","journal-title":"Clin Transplant"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.transproceed.2008.05.065","volume":"40","author":"Veroux M.","year":"2008","unstructured":"Veroux M.; Giuffrida G.; Corona D.; Gagliano M.; Scriffignano V.; Vizcarra D.; Tallarita T.; Zerbo D.; Virgilio C.; Sciacca A.; Cappello D.; Stefani S.; Veroux P.; Infective complications in renal allograft recipients: Epidemiology and outcome. Transplant Proc  2008,40(6),1873-1876","journal-title":"Transplant Proc"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/0971-4065.59333","volume":"19","author":"Najar M.S.","year":"2009","unstructured":"Najar M.S.; Saldanha C.L.; Banday K.A.; Approach to urinary tract infections. Indian J Nephrol  2009,19(4),129-139","journal-title":"Indian J Nephrol"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1399-0012.1997.tb00850.x","volume":"11","author":"Moys\u00e9s Neto M.","year":"1997","unstructured":"Moys\u00e9s Neto M.; Costa R.S.; Reis M.A.; Ferraz A.S.; Saber L.T.; Batista M.E.; Muglia V.; Garcia T.M.; Figueiredo J.F.; Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients. Clin Transplant  1997,11(5 Pt 1),446-452","journal-title":"Clin Transplant"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/ndt\/gfz261","volume":"35","author":"Rosado-Canto R.","year":"2020","unstructured":"Rosado-Canto R.; Parra-Avila I.; Tejeda-Maldonado J.; Kauffman-Ortega C.; Rodriguez-Covarrubias F.T.; Trujeque-Matos M.; Cruz-Mart\u00ednez R.; Maravilla-Franco E.; Criollo-Mora E.; Arreola-Guerra J.M.; Morales-Buenrostro L.E.; Sifuentes-Osornio J.; Perioperative fosfomycin disodium prophylaxis against urinary tract infection in renal transplant recipients: A randomized clinical trial. Nephrol Dial Transplant  2020,35(11),1996-2003","journal-title":"Nephrol Dial Transplant"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e12828","DOI":"10.1111\/tid.12828","volume":"20","author":"Hollyer I.","year":"2018","unstructured":"Hollyer I.; Ison M.G.; The challenge of urinary tract infections in renal transplant recipients. Transpl Infect Dis  2018,20(2),e12828","journal-title":"Transpl Infect Dis"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"195","DOI":"10.12659\/AOT.883901","volume":"18","author":"Ariza-Heredia E.J.","year":"2013","unstructured":"Ariza-Heredia E.J.; Beam E.N.; Lesnick T.G.; Kremers W.K.; Cosio F.G.; Razonable R.R.; Urinary tract infections in kidney transplant recipients: Role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transplant  2013,18,195-204","journal-title":"Ann Transplant"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40620-019-00585-3","volume":"32","author":"Fiorentino M.","year":"2019","unstructured":"Fiorentino M.; Pesce F.; Schena A.; Simone S.; Castellano G.; Gesualdo L.; Updates on urinary tract infections in kidney transplantation. J Nephrol  2019,32(5),751-761","journal-title":"J Nephrol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/ajt.12098","volume":"13","author":"Garzoni C.","year":"2013","unstructured":"Garzoni C.; Vergidis P.; Methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections in solid organ transplantation. Am J Transplant  2013,13(Suppl. 4),50-58","journal-title":"Am J Transplant"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1592\/phco.31.6.527","volume":"31","author":"Kullar R.","year":"2011","unstructured":"Kullar R.; Davis S.L.; Levine D.P.; Zhao J.J.; Crank C.W.; Segreti J.; Sakoulas G.; Cosgrove S.E.; Rybak M.J.; High-dose daptomycin for treatment of complicated gram-positive infections: A large, multicenter, retrospective study. Pharmacotherapy  2011,31(6),527-536","journal-title":"Pharmacotherapy"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12879-014-0687-9","volume":"14","author":"Chuang Y.C.","year":"2014","unstructured":"Chuang Y.C.; Wang J.T.; Lin H.Y.; Chang S.C.; Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: Systematic review and meta-analysis. BMC Infect Dis  2014,14(1),687","journal-title":"BMC Infect Dis"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000296303","volume":"85","author":"Salehipour M.","year":"2010","unstructured":"Salehipour M.; Salahi H.; Fathikalajahi A.; Mohammadian R.; Emadmarvasti V.; Bahador A.; Nikeghbalian S.; Kazemi K.; Dehghani M.; Malek-Hosseini S.A.; Is perioperative intravesically applied antibiotic solution effective in the prophylaxis of urinary tract infections after renal transplantation? Urol Int  2010,85(1),66-69","journal-title":"Urol Int"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/15269248211064880","volume":"32","author":"Sweiss H.","year":"2022","unstructured":"Sweiss H.; Bhayana S.; Hall R.; Nelson J.; Kincaide E.; Methenamine for recurrent urinary tract infections in solid organ transplantation. Prog Transplant  2022,32(1),67-72","journal-title":"Prog Transplant"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/21505594.2016.1139279","volume":"7","author":"Kritikos A.","year":"2016","unstructured":"Kritikos A.; Manuel O.; Bloodstream infections after solid-organ transplantation. Virulence  2016,7(3),329-340","journal-title":"Virulence"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/ajt.12124","volume":"13","author":"Parasuraman R.","year":"2013","unstructured":"Parasuraman R.; Julian K.; Urinary tract infections in solid organ transplantation. Am J Transplant  2013,13(Suppl. 4),327-336","journal-title":"Am J Transplant"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.21037\/apm-21-777","volume":"10","author":"Jin M.","year":"2021","unstructured":"Jin M.; Zeng L.; Zhang W.; Deng X.; Li J.; Zhang W.; Clinical features of multidrug-resistant organism infections in early postoperative solid organ transplantation in a single center. Ann Palliat Med  2021,10(4),4555-4562","journal-title":"Ann Palliat Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4103\/lungindia.lungindia_99_22","volume":"39","author":"Bhadauria D.","year":"2022","unstructured":"Bhadauria D.; Jain S.; Prasad R.; Gurjar M.; Yaccha M.; Shanmugham S.; Kaul A.; Rungmei Marak S.K.; Nath A.; Prasad N.; Aetiology, management, and outcome of lower respiratory tract infection in renal allograft recipients \u2013 A report from a tropical country. Lung India  2022,39(6),545-552","journal-title":"Lung India"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1128\/CMR.00068-15","volume":"29","author":"Falagas M.E.","year":"2016","unstructured":"Falagas M.E.; Vouloumanou E.K.; Samonis G.; Vardakas K.Z.; Fosfomycin. Clin Microbiol Rev  2016,29(2),321-347","journal-title":"Clin Microbiol Rev"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.transproceed.2022.05.005","volume":"54","author":"Ono K.","year":"2022","unstructured":"Ono K.; Ishibashi Y.; Kaname S.; Successful kidney and hematopoietic stem cell transplantation for malignant lymphoma from different donors: A case report and literature review. Transplant Proc  2022,54(6),1589-1593","journal-title":"Transplant Proc"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3390\/diagnostics11081456","volume":"11","author":"Su\u00e1rez Fern\u00e1ndez M.L.","year":"2021","unstructured":"Su\u00e1rez Fern\u00e1ndez M.L.; Ridao Cano N.; \u00c1lvarez Santamarta L.; Gago Fraile M.; Blake O.; D\u00edaz Corte C.; A current review of the etiology, clinical features, and diagnosis of urinary tract infection in renal transplant patients. Diagnostics (Basel)  2021,11(8),1456","journal-title":"Diagnostics (Basel)"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00120-023-02059-8","volume":"62","author":"Stangl FP","year":"2023","unstructured":"Stangl FP; Godly J; Kranz J; Neumann T; Schneidewind L; Do we need to treat asymptomatic bacteriuria in immunocompromised patients?: A rapid review. Urologie  2023,62(6),609-614","journal-title":"Urologie"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/INF.0000000000003735","volume":"42","author":"Gainey A.B.","year":"2023","unstructured":"Gainey A.B.; Daniels R.; Burch A.K.; Hawn J.; Fackler J.; Biswas B.; Brownstein M.J.; Recurrent ESBL Escherichia coli urosepsis in a pediatric renal transplant patient treated with antibiotics and bacteriophage therapy. Pediatr Infect Dis J  2023,42(1),43-46","journal-title":"Pediatr Infect Dis J"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/INF.0000000000003701","volume":"41","author":"Cruz A.T.","year":"2022","unstructured":"Cruz A.T.; Tanverdi M.S.; Swartz S.J.; Dayan P.S.; Combs V.A.; Lubell T.R.; Frequency of bacteremia and urinary tract infection in pediatric renal transplant recipients. Pediatr Infect Dis J  2022,41(12),997-1003","journal-title":"Pediatr Infect Dis J"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.36290\/vnl.2022.041","volume":"68","author":"Lys Z.","year":"2022","unstructured":"Lys Z.; Dombrovsk\u00e1 K.; D\u011bdochov\u00e1 J.; Kov\u00e1\u0159ov\u00e1 P.; Valkovsk\u00fd I.; V\u00e1clav\u00edk J.; Acute infections in kidney transplant recipients. Vnitr Lek  2022,68(3),E12-E17","journal-title":"Vnitr Lek"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.11817\/j.issn.1672-7347.2022.220054","volume":"47","author":"Wu X","year":"2022","unstructured":"Wu X; Wu L; Wan Q; Pathogen distribution and risk factors of bacterial and fungal infections after liver transplantation. Zhong Nan Da Xue Xue Bao Yi Xue Ban  2022,47(8),1120-1128","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1016\/j.transproceed.2021.08.056","volume":"53","author":"Harris T.N.","year":"2021","unstructured":"Harris T.N.; Szempruch K.R.; Dupuis R.E.; Serrano Rodriguez P.; Toledo A.H.; Alemtuzumab in renal retransplantation \u2013 transplant outcomes and associated infections. Transplant Proc  2021,53(10),2888-2894","journal-title":"Transplant Proc"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1111\/bcp.15385","volume":"88","author":"Huang X.","year":"2022","unstructured":"Huang X.; Zhou Y.; Zhang J.; Xiang H.; Mei H.; Liu L.; Tong L.; Zeng F.; Huang Y.; Zhou H.; Zhang Y.; The importance of CYP2C19 genotype in tacrolimus dose optimization when concomitant with voriconazole in heart transplant recipients. Br J Clin Pharmacol  2022,88(10),4515-4525","journal-title":"Br J Clin Pharmacol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.12890\/2022_003528","volume":"9","author":"Shah A.","year":"2022","unstructured":"Shah A.; Nasrullah A.; Butt M.A.; Young M.; Paxlovid with Caution: Novel case of paxlovid-induced tacrolimus toxicity in a cardiac transplant patients. Eur J Case Rep Intern Med  2022,9(9),11","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"21389","DOI":"10.1038\/s41598-021-00942-y","volume":"11","author":"D\u00e9ri M.","year":"2021","unstructured":"D\u00e9ri M.; Szak\u00e1l-T\u00f3th Z.; Fekete F.; Mang\u00f3 K.; Incze E.; Minus A.; Merkely B.; Sax B.; Monostory K.; CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients. Sci Rep  2021,11(1),21389","journal-title":"Sci Rep"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/ehf2.13835","volume":"9","author":"Tsuji M.","year":"2022","unstructured":"Tsuji M.; Kakuda N.; Bujo C.; Ishida J.; Amiya E.; Hatano M.; Shimada A.; Imai H.; Shimada S.; Kinoshita O.; Yamauchi H.; Ono M.; Komuro I.; Sarcopenia and risk of infection in adult heart transplant recipients in Japan. ESC Heart Fail  2022,9(2),1413-1423","journal-title":"ESC Heart Fail"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1111\/ajt.13486","volume":"15","author":"Martin-Gandul C.","year":"2015","unstructured":"Martin-Gandul C.; Mueller N.J.; Pascual M.; Manuel O.; The impact of infection on chronic allograft dysfunction and allograft survival after solid organ transplantation. Am J Transplant  2015,15(12),3024-3040","journal-title":"Am J Transplant"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"e14209","DOI":"10.1111\/tid.14209","volume":"26","author":"Kozuch J.M.","year":"2024","unstructured":"Kozuch J.M.; Burt C.; Afshar K.; Aslam S.; Yung G.; Mariski M.; Golts E.; Feist A.; Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients. Transpl Infect Dis  2024,26(1),e14209","journal-title":"Transpl Infect Dis"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/pros.24675","volume":"84","author":"Romano L.","year":"2024","unstructured":"Romano L.; Napolitano L.; Crocetto F.; Sciorio C.; Sio M.D.; Miranda A.; Romano M.; Priadko K.; Prostate and gut: Any relationship? A narrative review on the available evidence and putative mechanisms. Prostate  2024,84(6),513-524","journal-title":"Prostate"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1515\/CCLM.2000.190","volume":"38","author":"Tolou-Ghamari Z.","year":"2000","unstructured":"Tolou-Ghamari Z.; Wendon J.; Tredger J.M.; In vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation. Clin Chem Lab Med  2000,38(11),1209-1211","journal-title":"Clin Chem Lab Med"},{"key":"ref=100","unstructured":"HYPERLINK \"https:\/\/www.scopus.com\/authid\/detail.uri?authorId=6603144440andeid=2-s2.0-1042304276\"Tolou-Ghamari Z,  HYPERLINK \"https:\/\/www.scopus.com\/authid\/detail.uri?authorId=56177794500andeid=2-s2.0-1042304276\"Palizban AA. Laboratory Monitoring of Cyclosporine Pre-Dose Concentration (C0) after Kidney Transplantation in Isfahan. IJMS. 2003 Jun; 28(2): 81-85."}],"container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871315445240916091528","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/234503\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871315445240916091528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:03:44Z","timestamp":1740719024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/234503\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115748871315445240916091528","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}